Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Qiagen's Clinical Interpretation Tools; Station X's GenePool Reference; More


Qiagen has announced the impending launches of clinical interpretation tools CLC Cancer Research Workbench and Ingenuity Clinical. CLC Cancer Research Workbench will launch in April 2014 and is a cancer-specific analysis workflow that interprets next-gen sequencing data. Ingenuity Clinical is being used by 20 clinical testing laboratories in early access and will launch commercially later this year. The solution does automated scoring, interpretation, and reporting of findings in standardized, HIPPA-compliant formats.

Station X has launched GenePool Reference, software for the management, sharing, and analysis of population-scale genomic data. The firm has made available all of the gene expression data from the Cancer Genome Atlas, which includes RNA-seq data covering 25 cancer types. In total, GenePool Reference currently contains over 7,000 samples of DNA and RNA sequence data.

Connective Tissue Gene Tests has added deletion and duplication testing to 12 of its Sanger sequencing tests to diagnose genetic forms of connective tissue disorders. The company offers a total of 33 Sanger-based tests and nine next-gen sequencing-based gene panels.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.